Please turn JavaScript on

JUVE Patent

Subscribe to JUVE Patent’s news feed.

Click on “Follow” and decide if you want to get news from JUVE Patent via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to JUVE Patent comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from JUVE Patent which you are really interested in. Click on the blue “Filter” button below to get started.

Title: JUVE Patent

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.8 / day

Message History

The parties are fighting over EP 1 467 728. The patent protects the combination of the angiotensin receptor blocker valsartan and the neutral endopeptidase inhibitor sacubitril. The two compounds form the basis of Novartis’ drug Entresto, us...


Read full story

Edwards began his career as a trainee solicitor at Linklaters in 2000, before joining Bird & Bird as a solicitor in 2002. In 2007, he moved to Australian firm Freehills as a senior associate, having previously spent time at Mallesons Stephen Jaques.

In 2011, Edwards transitioned in-house, joining generics manufacturer Sandoz in the German town of Holzkirchen as pat...


Read full story

Atlas Global Technologies, a US-based non-practising entity, owns the two patents EP 3 353 901 and EP 3 186 ...


Read full story

The rulings mark the latest chapter in a long-running dispute in which US patent holder WobbleWorks is defending its 3Doodler technology against various Asian competitors. The current dispute revolves around WobbleWorks’ EP 3 698 938 B1, which protects a hand-held ...


Read full story

Japanese consumer electronics company Maxell had sued four Samsung entities before the UPC’s local division The Hague, alleging that various Galaxy smartphones and tablets infringed device claims of EP 2 061 230. The patent, granted in 2011 and validated in France,...


Read full story